LeonaBio, Inc. Variable Lease, Cost
LeonaBio, Inc. (LONA) reported Variable Lease, Cost of $20.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-14
- LeonaBio, Inc. variable lease, cost for the quarter ending 2026-06-30 was $20.00K, a 51.22% decline year-over-year.
- LeonaBio, Inc. variable lease, cost for the quarter ending 2026-03-31 was $27.00K, a 40.00% decline year-over-year.
- LeonaBio, Inc. variable lease, cost for the quarter ending 2025-12-31 was $46.00K, a 12.20% increase year-over-year.
- LeonaBio, Inc. variable lease, cost for the quarter ending 2025-09-30 was $45.00K, a 9.76% increase year-over-year.
- LeonaBio, Inc. variable lease, cost for fiscal 2025 was $177.00K, a 18.79% increase from fiscal 2024.
- LeonaBio, Inc. variable lease, cost for fiscal 2024 was $149.00K, a 19.89% decline from fiscal 2023.
- LeonaBio, Inc. variable lease, cost for fiscal 2023 was $186.00K, a 11.38% increase from fiscal 2022.
- LeonaBio, Inc. variable lease, cost for fiscal 2022 was $167.00K, a 54.63% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-14 | $47.00K 10-Q · filed 2026-08-14 | $93.00K derived: sum of 3 quarters · filed 2026-08-14 | $138.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $27.00K 10-Q · filed 2026-05-07 | $73.00K derived: sum of 2 quarters · filed 2026-05-07 | $118.00K derived: sum of 3 quarters · filed 2026-05-07 | $159.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $91.00K derived: sum of 2 quarters · filed 2026-03-31 | $132.00K derived: sum of 3 quarters · filed 2026-08-14 | $177.00K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $45.00K 10-Q · filed 2025-11-06 | $86.00K derived: sum of 2 quarters · filed 2026-08-14 | $131.00K 10-Q · filed 2025-11-06 | $172.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $41.00K 10-Q · filed 2026-08-14 | $41.00M 10-Q · filed 2025-08-07 | $86.00K 10-Q · filed 2026-08-14 | $86.00M 10-Q · filed 2025-08-07 | $127.00K derived: sum of 3 quarters · filed 2026-08-14 | $168.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $45.00K 10-Q · filed 2026-05-07 | $86.00K derived: sum of 2 quarters · filed 2026-05-07 | $127.00K derived: sum of 3 quarters · filed 2026-05-07 | $41.13M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $82.00K derived: sum of 2 quarters · filed 2026-03-31 | $41.08M derived: sum of 3 quarters · filed 2026-03-31 | $149.00K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $41.00K 10-Q · filed 2025-11-06 | $41.04M derived: sum of 2 quarters · filed 2025-11-06 | $108.00K 10-Q · filed 2025-11-06 | $41.11M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $41.00M 10-Q · filed 2025-08-07 | $67.00M 10-Q · filed 2025-08-07 | $41.07M derived: sum of 3 quarters · filed 2025-08-07 | $41.11M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $26.00K 10-Q · filed 2025-05-09 | $26.00M 10-Q · filed 2024-05-15 | $68.00K derived: sum of 2 quarters · filed 2025-05-09 | $110.00K derived: sum of 3 quarters · filed 2025-05-09 | $42.11M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $84.00K derived: sum of 2 quarters · filed 2025-02-27 | $42.08M derived: sum of 3 quarters · filed 2025-02-27 | $186.00K 10-K · filed 2025-02-27 | ||
| 2023-09-30 | $42.00K 10-Q · filed 2024-11-07 | $42.04M derived: sum of 2 quarters · filed 2024-11-07 | $144.00K 10-Q · filed 2024-11-07 | $102.08M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $42.00M 10-Q · filed 2024-08-01 | $102.00M 10-Q · filed 2024-08-01 | $102.04M derived: sum of 3 quarters · filed 2024-08-01 | $102.08M derived: sum of 4 quarters · filed 2024-08-01 | ||
| 2023-03-31 | $60.00M 10-Q · filed 2024-05-15 | $60.04M derived: sum of 2 quarters · filed 2024-05-15 | $60.08M derived: sum of 3 quarters · filed 2024-05-15 | $101.08M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $82.00K derived: sum of 2 quarters · filed 2024-02-22 | $41.08M derived: sum of 3 quarters · filed 2024-02-22 | $167.00K 10-K · filed 2024-02-22 | ||
| 2022-09-30 | $41.00K 10-Q · filed 2023-11-09 | $41.04M derived: sum of 2 quarters · filed 2023-11-09 | $126.00K 10-Q · filed 2023-11-09 | $85.08M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $41.00M 10-Q · filed 2023-08-10 | $41.00K 10-Q · filed 2022-08-15 | $85.00M 10-Q · filed 2023-08-10 | $85.00K 10-Q · filed 2022-08-15 | $85.03M derived: sum of 3 quarters · filed 2023-08-10 | $85.07M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $44.00M 10-Q · filed 2023-05-11 | $44.00K 10-Q · filed 2022-05-12 | $44.03M derived: sum of 2 quarters · filed 2023-05-11 | $44.07M derived: sum of 3 quarters · filed 2023-05-11 | $44.09M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $68.00K derived: sum of 2 quarters · filed 2023-03-23 | $88.00K derived: sum of 3 quarters · filed 2023-03-23 | $108.00K 10-K · filed 2023-03-23 | ||
| 2021-09-30 | $33.00K 10-Q · filed 2022-11-10 | $53.00K derived: sum of 2 quarters · filed 2022-11-10 | $73.00K 10-Q · filed 2022-11-10 | $73.00K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $20.00K 10-Q · filed 2022-08-15 | $40.00K 10-Q · filed 2022-08-15 | $40.00K derived: sum of 3 quarters · filed 2022-08-15 | $40.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $20.00K 10-Q · filed 2022-05-12 | $20.00K derived: sum of 2 quarters · filed 2022-05-12 | $20.00K derived: sum of 3 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |